Drawing for XTENDYOUTH

USPTO serial 87181841

XTENDYOUTH

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
THOMAS, JULIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XTENDYOUTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicated creams for treating dermatological conditions; Nutritional supplements for anti-aging; Nutritional supplements for boosting energy; Pharmaceutical agents affecting metabolism; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating skin disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Therapeutic pharmaceutical for the treatment of inflammatory conditions that cause aging; Therapeutic pharmaceutical for the treatment of immune disorders; Therapeutic pharmaceutical for the treatment of transplant rejection; Therapeutic pharmaceutical for the treatment of inflammatory diseases; Therapeutic pharmaceutical for the treatment of acute radiation sickness; Therapeutic pharmaceutical for the treatment of infertility; Therapeutic pharmaceutical for the treatment of pregnancy disordersABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2017MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
May 24, 2017ABN5ABANDONMENT - AFTER PUBLICATION—
May 23, 2017EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 2, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 30, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 11, 2017ALIEASSIGNED TO LIE—
Dec 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 30, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 30, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 30, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 30, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 29, 2016DOCKASSIGNED TO EXAMINER—
Sep 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance